2012 HALF-YEAR RESULTS

 
 
 
 

Longjumeau, September 6th, 2012

Business buoyant over the first half of 2012 - Strong growth in results

In millions of euros H1 - 2011 H1 - 2012% change
Net sales 85.8 89.4+ 4.1%
including Pharmaceutical Synthesis   53.6     55.4  
including Fine Specialty Chemicals   32.2     34.0  
EBITDA (*) 9.5 13.1+ 37.9%
EBITDA margin   11.1%     14.6%  
Current Operating Income (*) 4.1 7.4+ 80.5%
Other operating income and expenses  -0.3  -1.3
Financial Result  -1.4  -1.9
Share of profit/loss of associates 0.1  -0.1
Taxes  -0.3  -0.5
Net Result 2.2 3.6+ 63.6%
In millions of euros Dec. 31, 2011 June 30, 2012
Equity 69.2 73.0
Net debt 53.6 55.9
Gearing   0.77     0.77  
Net asset per share 5.0 5.3
(*) of which research tax credit (CIR): 1.4 million euros in 2011 and 2012  

The PCAS Group achieved 4.1% growth in consolidated net sales for the first half of 2012 compared to the first half of 2011.

Pharmaceutical Synthesis
Net sales are up 3.3%. Excluding the contract between PCAS and Sanofi, this division's sales increased by 7.7% compared to the first half of 2011.

Fine Specialty Chemicals
The Fine Specialty Chemicals business has recorded 5.5% growth in 2012, driven by the New Technologies activities, while the Performance Chemicals and Fragrance-Flavor-Cosmetics lines contracted slightly over the period.

Current operating income reached 7.4 million euros for the first half of 2012, compared to 4.1 million euros for the first half of 2011, reflecting this increase in business and a significant improvement in margins.

The PCAS Group recorded 3.6 million euros in net income for the first half of 2012, versus 2.2 million euros for the first half of 2011, taking into account -1.3 million euros in other operating income and expenses (including 0.8 million euros of restructuring costs) and
-1.9 million euros in financial expenses.

The second half of the year should see as well an increase of volume of business, stronger than the second half of 2011, for each division, despite a contraction for Fragrance activities.

Business and earnings are historically higher for the first six months than the second half of the year, which is affected by the annual site shutdowns.

About PCAS :
 
 

Founded in 1962, PCAS is a fine and specialty chemicals group that shares an ambition for excellence with its customers, which primarily include market-leading international groups. PCAS designs and delivers the best industrial solutions for its customers' specific expectations. These various expectations all share a common demand for safety, quality, competitiveness, innovation and sustainability.

Financial Communications: Vincent Touraille - Eric Moissenot | Tel +33 (0)1 69 09 77 85 | www.pcas.com:
http://www.pcas.com/

 
 
 
PCAS : 2012 Half-Year Results:
http://hugin.info/143512/R/1639298/527534.pdf


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: PCAS via Thomson Reuters ONE
HUG#1639298